GlaxoSmithKline (GSKL)

1,309.50p
   
  • Change Today:
      7.50p
  • 52 Week High: 1,812.75
  • 52 Week Low: 1,302.00
  • Currency: UK Pounds
  • Shares Issued: 4,870.09m
  • Volume: 1,034,469
  • Market Cap: £63,774m

GlaxoSmithKline Overview

We are a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of 2030. Our bold ambitions for patients are reflected in commitments to growth and a step-change in performance. We are a company where outstanding people can thrive.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.9%
Div Cover n/a
Op Mrgn n/a
ROCE n/a
Latest F'cast
P/E 39.5
PEG n/a
Pr/Revenue 11.3
Pr/Book 6.3
Latest F'cast
Revenue n/a
PBT 7.7%
EPS n/a
DPS n/a

GlaxoSmithKline Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-19 33,754.00 6,221.00 123.90p 17.9 4.5 +4% 80.00p 3.6%
31-Dec-20 34,099.00 6,968.00 115.90p 14.5 n/a -6% 80.00p 4.8%
31-Dec-21 24,696.00 3,599.00 90.56p 22.2 n/a -22% 80.00p 4.0%
31-Dec-22 29,324.00 5,628.00 139.70p 10.3 0.2 +54% 44.00p 3.1%
31-Dec-23 30,328.00 6,064.00 155.10p 9.4 0.9 +11% 42.00p 2.9%

GlaxoSmithKline Company Announcements

No recent information was found.

GlaxoSmithKline ShareCast News

Tuesday broker round-up 09-Mar-2021 ShareCast

Latest GlaxoSmithKline Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 5 minutes.

Note 2: Forecast figures based on normalised accounts.

 

GlaxoSmithKline Market Data

Currency UK Pounds
Share Price 1,309.50p
Change Today 7.50p
% Change 0.58 %
52 Week High 1,812.75
52 Week Low 1,302.00
Volume 1,034,469
Shares Issued 4,870.09m
Market Cap £63,774m

Trades for 21-Nov-2024

Time Volume / Share Price
16:29 126 @ 1,309.50p
16:29 30 @ 1,309.50p
16:29 385 @ 1,309.50p
16:29 150 @ 1,309.50p
16:29 642 @ 1,310.00p

GlaxoSmithKline Key Personnel

CEO Emma Walmsley

Top of Page